Bellerophon Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Bellerophon Therapeutics

15/11/2021 15:57

* Bellerophon Therapeutics Inc  BLPH.OQ  reported a quarterly
adjusted loss of 49 cents​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for a loss of 63 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Bellerophon Therapeutics Inc's reported EPS for the quarter
was a loss of 49 cents​.
* The mean earnings estimate of analysts had risen by about 5.5%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Bellerophon Therapeutics Inc shares had fallen by 22.7% this
quarter and lost 52.9% so far this year.
* The company reported a quarterly loss of $4.63 million.
* Wall Street's median 12-month price target for Bellerophon
Therapeutics Inc is $22.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 15 at 03:57 p.m.
 ​All figures in US dollars unless otherwise stated